Original Research
Accepted on 30 May 2025
Development and Validation of the Pediatrics Functional Living Index-Emesis (PFLIE) Scale
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1573996
- Frontiers in Oncology
- Pediatric Oncology
- Articles
Type at least 3 characters
576 articles
Review
Accepted on 30 May 2025
Fusion Oncogenes in Rhabdomyosarcoma: Model Systems, Mechanisms of Tumorigenesis, and Therapeutic Implications
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1570070
Systematic Review
Published on 30 May 2025
Non-cancer effects after proton beam therapy for pediatric tumors- a narrative review
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1554765
- 332 views
Original Research
Accepted on 28 May 2025
Hypoalbuminemia is associated with adverse outcomes in critically ill children with cancer
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1576639
Original Research
Accepted on 26 May 2025
Establishing Preclinical Models for Clear Cell Sarcoma of Soft Tissue
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1589773
- 131 views
Perspective
Accepted on 26 May 2025
New perspectives on extracorporeal life support: expert teams and precise selection of candidates are transforming pediatric cancer and hematopoietic cell transplantation care
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1588403
Original Research
Accepted on 23 May 2025
Clinician Perspectives on Multilevel Impacts of Pediatric Early Warning Systems (PEWS) in Resource-Variable Hospitals
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1573360
- 110 views
Review
Accepted on 21 May 2025
Aberrant Histone modifications in pediatric brain tumors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1587157
- 133 views
Original Research
Published on 21 May 2025
A dual readout embryonic zebrafish xenograft model of rhabdomyosarcoma to assess clinically relevant multi-receptor tyrosine kinase inhibitors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1547202
- 454 views
Original Research
Accepted on 20 May 2025
Contemporary Epidemiological Landscape of Pediatric non-Hodgkin Lymphoma: A Global Burden of Disease Analysis
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1606627
Systematic Review
Published on 20 May 2025
Cumulative temporal association between assisted reproductive technology and childhood cancer: a systematic review and meta-analysis of observational studies
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1555420
- 416 views
Case Report
Published on 20 May 2025
Case Report: A novel germline donor splicing site mutation of RB1 gene in a Chinese Tibetan pedigree with familial retinoblastoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1525035
- 356 views
Case Report
Published on 16 May 2025
Synchronous childhood T-lymphoblastic lymphoma and B-cell precursor acute lymphoblastic leukemia associated with constitutional MMR deficiency syndrome –a case report
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1580494
- 400 views
Case Report
Accepted on 15 May 2025
Rare Manifestations of Pediatric Chronic Myeloid Leukemia: A Case Report on Priapism and a Literature Review
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1579981
- 160 views
Original Research
Accepted on 12 May 2025
A Reduced-Toxicity Myeloablative Conditioning approach for Hematopoietic Cell Transplant in Juvenile Myelomonocytic Leukemia
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1541192
- 180 views
Original Research
Accepted on 12 May 2025
Gram-negative Blood-stream Infections and Emerging Antimicrobial resistance (AMR) in Children with Acute Myeloid Leukemia during Induction Chemotherapy at Children's Cancer Hospital Egypt 57357
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1540831